tiprankstipranks
Gri Bio, Inc. (GRI)
NASDAQ:GRI
US Market

GRI Bio (GRI) Income Statement

362 Followers

GRI Bio Income Statement

Last quarter (Q4 2025), GRI Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, GRI Bio's net income was $-2.66M. See GRI Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Dec 22Dec 21
Total Revenue
$ 0.00$ 22.54M$ 0.00$ 0.00$ 0.00
Gross Profit
$ -4.00K$ -4.00K$ -57.00K$ -50.00K$ -73.00K
Operating Expenses
$ 11.98M$ 8.23M$ 11.33M$ 2.19M$ 9.19M
Depreciation and Amortization
$ 4.00K$ 4.00K$ 57.00K$ 50.00K$ 73.00K
EBITDA
$ -11.97M$ -8.20M$ -10.90M$ -2.51M$ -9.21M
Operating Income
$ -11.98M$ -8.23M$ -11.39M$ -2.24M$ -9.26M
Other Income/Expenses
$ 21.00K$ 28.00K$ -1.65M$ -978.00K$ -44.00K
Pretax Income
$ -11.96M$ -8.21M$ -13.04M$ -3.22M$ -9.30M
Net Income
$ -11.96M$ -8.21M$ -13.04M$ -3.22M$ -9.30M
Per Share Metrics
Basic EPS
$ -121.80$ -1.55K$ -140.45K$ -47.14K$ -2.83K
Diluted EPS
$ -121.80$ -1.55K$ -140.45K$ -47.14K$ -2.83K
Weighted Average Shares Outstanding
98.16K 6.55K 1.58K 1.16K 11.60K
Weighted Average Shares Outstanding (Diluted)
98.16K 6.55K 1.58K 1.16K 11.60K
Currency in USD

GRI Bio Earnings and Revenue History